GlassScriptPhysician profile
Emily Rodgers
NPI 1497484562
$1,145.01
in general payments reported to CMS, 2019-2025
12 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $42.94 · 2023: $334 · 2024: $424 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,102.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $220.22 | 2023-2025 | |
| Gynesonics, INC. | $138.71 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sumitomo Pharma America, INC. | $122.55 | 2023 | Myfembree |
| Axonics, INC. | $110.53 | 2024 | Bulkamid |
| Minerva Surgical, INC | $108.75 | 2024 | |
| Astellas Pharma US INC | $97.96 | 2023 | Veozah |
| Heron Therapeutics, INC. | $97.02 | 2025 | Zynrelef |
| Biogen, INC. | $92.92 | 2025 | Zurzuvae |
| Mimedx Group, INC. | $48.00 | 2024 | |
| Boston Scientific Corporation | $46.94 | 2025 | Angiojet Ultra 5000a |
| Medtronic, INC. | $42.94 | 2022 | |
| Stryker Corporation | $18.47 | 2024 | Stryker |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Rodgers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.